Rana Soylu Kucharz

affiliated with the university
More filtering options
  1. 2020
  2. 2019
  3. Apolipoprotein M-bound sphingosine-1-phosphate regulates blood-brain barrier paracellular permeability and transcytosis

    Mette Mathiesen Janiurek, Rana Soylu-Kucharz, Christina Christoffersen, Krzysztof Kucharz & Martin Lauritzen, 2019 Nov 25, In : eLife. 8

    Research output: Contribution to journalArticle

  4. SIRT1 is increased in affected brain regions and hypothalamic metabolic pathways are altered in Huntington disease

    B. Baldo, S. Gabery, R. Soylu-Kucharz, R. Y. Cheong, J. B. Henningsen, E. Englund, C. McLean, D. Kirik, G. Halliday & Petersén, 2019, In : Neuropathology and Applied Neurobiology. 45, 4, p. 361-379

    Research output: Contribution to journalArticle

  5. 2017
  6. Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease

    Rana Soylu-Kucharz, Åsa Sandelius, Marie Sjögren, Kaj Blennow, Edward J. Wild, Henrik Zetterberg & Maria Björkqvist, 2017 Dec 1, In : Scientific Reports. 7, 1, 14114.

    Research output: Contribution to journalArticle

  7. 2016
  8. Hypothalamic and Metabolic Dysfunction in Genetic Models of Huntington’s Disease

    Rana Soylu Kucharz, 2016, Lund: Lund University: Faculty of Medicine. 92 p.

    Research output: ThesisDoctoral Thesis (compilation)

  9. 2015
  10. Hypothalamic overexpression of mutant huntingtin causes dysregulation of brown adipose tissue.

    Rana Soylu, Natalie Adlesic, Barbara Baldo, Deniz Kirik & Åsa Petersén, 2015, In : Scientific Reports. 5, 14598.

    Research output: Contribution to journalArticle

  11. Low dietary protein content alleviates motor symptoms in mice with mutant dynactin/dynein-mediated neurodegeneration.

    Diana Wiesner, Jérome Sinniger, Alexandre Henriques, Stéphane Dieterlé, Hans-Peter Müller, Volker Rasche, Boris Ferger, Sylvie Dirrig-Grosch, Rana Soylu, Åsa Petersén, Paul Walther, Birgit Linkus, Jan Kassubek, Philip C Wong, Albert C Ludolph & Luc Dupuis, 2015, In : Human Molecular Genetics. 24, 8, p. 2228-2240

    Research output: Contribution to journalArticle

  12. 2013
  13. Maintenance of Basal Levels of Autophagy in Huntington's Disease Mouse Models Displaying Metabolic Dysfunction.

    Barbara Baldo, Rana Soylu & Åsa Petersén, 2013, In : PLoS ONE. 8, 12, e83050.

    Research output: Contribution to journalArticle

  14. 2012
  15. 2011
  16. Increased numbers of orexin/hypocretin neurons in a genetic rat depression model.

    Elli Mikrouli, Gitta Wörtwein, Rana Soylu, Aleksander A Mathe & Åsa Petersén, 2011, In : Neuropeptides. 45, p. 401-406

    Research output: Contribution to journalArticle

  17. Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits.

    Sofia Hult Lundh, Rana Soylu, Tomas Björklund, Bengt F Belgardt, Jan Mauer, Jens C Brüning, Deniz Kirik & Åsa Petersén, 2011, In : Cell Metabolism. 13, 4, p. 428-439

    Research output: Contribution to journalArticle

  18. 2010
  19. A point mutation in the dynein heavy chain gene leads to striatal atrophy and compromises neurite outgrowth of striatal neurons

    Kerstin E. Braunstein, Judith Eschbach, Krisztina Rona-Voeroes, Rana Soylu, Elli Mikrouli, Yves Larmet, Frederique Rene, Jose-Luis Gonzalez De Aguilar, Jean-Philippe Loeffler, Hans-Peter Mueller, Selina Bucher, Thomas Kaulisch, Heiko G. Niessen, Julia Tillmanns, Kristina Fischer, Birgit Schwalenstoecker, Jan Kassubek, Bernd Pichler, Detlef Stiller, Åsa Petersén & 2 others, Albert C. Ludolph & Luc Dupuis, 2010, In : Human Molecular Genetics. 19, 22, p. 4385-4398

    Research output: Contribution to journalArticle

  20. Hypothalamic and Neuroendocrine Changes in Huntington's Disease.

    Sofia Hult Lundh, Kristofer Schultz, Rana Soylu & Åsa Petersén, 2010, In : Current drug targets. 11, p. 1237-1249

    Research output: Contribution to journalArticle